We wish to express our enduring gratitude to medical professionals and all other people who make great efforts and sacrifices to support the sick and contain the further spread of infection by COVID-19.

Press Releases

Archives

2022.11.30

Submission of Application for Pre-Market Approval of the Paradise™ Ultrasound Renal Denervation (uRDN) System to the U.S. Food and Drug Administration

2022.11.21

Otsuka Medical Devices certified to ISO 13485 

2022.11.07

Announced Consistent Reduction of Blood Pressure in Pooled Analysis of Three Clinical Trials at AHA 2022 

2022.11.02

Veryan Medical announces the 36-month Outcomes for the BioMimics 3D Stent in Longer Lesions: A Subgroup Analysis of the MIMICS-3D EU Registry were presented at VIVA 22 (Link to Veryan website)

2022.10.07

BioMimics 3D Vascular Stent System granted Good Design Award 2022 

2022.09.20

Otsuka Medical Devices Announces Results of RADIANCE II Pivotal Trial at TCT 2022 Annual Meeting 

News

Archives

2022.04.21

Otsuka Group Joins RE100 International Initiative
- Committed to 100% Renewable Energy - (Link to Otsuka Holdings website)

2022.03.16

Otsuka Holdings Donations for Humanitarian Support to Ukrainian People (Link to Otsuka Holdings website)

2021.11.04

Otsuka Group Supports Recommendations of the Task Force on Climate-related Financial Disclosure (TCFD)
-Joins TCFD Consortium-(Link to Otsuka Holdings website)

2021.09.01

100th Anniversary of Otsuka Group of Companies Looking Ahead to the Next 100 Years (Link to Otsuka Holdings website)

About Otsuka Medical Devices Corporate Information CORPORATE PROFILE HARUMI Technology Center Otsuka group Sustainability website
Back to top
OTSUKA
Copyright (C) Otsuka Medical Devices Co., Ltd.